Financhill
Back

Candel Therapeutics Stock Predictions

Candel Therapeutics Stock Forecast

  • Is Candel Therapeutics Stock Undervalued?
    The current Candel Therapeutics [CADL] share price is $4.90. The Score for CADL is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • CADL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Candel Therapeutics Stock Go Up Next Year?

Data Unavailable

Candel Therapeutics Stock Rating

Data Unavailable

Candel Therapeutics Stock Price History

Is CADL stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CADL is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
candeltx.com

52-Week Data

52-Week High:
14.60
52-Week Low:
3.79

Prediction Charts

Market Cap:
245.5M
Price in USD:
4.90
Volume:
2.3M
Beta:
-0.89

Technical Analysis

SMA50:
5.18
SMA100:
6.46
SMA200:
6.44
52-Wk Change:
-16.81%

Stock Predictions

  • Is Candel Therapeutics stock public?
    Yes, Candel Therapeutics is a publicly traded company.
  • What is the Candel Therapeutics stock quote today?
    The Candel Therapeutics stock price is 4.90 USD today.
  • How to buy Candel Therapeutics stock online?
    You can buy Candel Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-9 6.16 5.86 6.17 5.78
Jun-10 5.89 5.85 6.15 5.82
Jun-11 5.85 5.46 5.90 5.44
Jun-12 5.40 5.36 5.58 5.26
Jun-13 5.28 5.13 5.44 5.03
Jun-16 5.18 5.16 5.34 5.08
Jun-17 5.10 4.94 5.18 4.94
Jun-18 5.00 4.92 5.09 4.84
Jun-20 5.17 4.75 5.17 4.72
Jun-23 4.71 4.67 4.72 4.48
Jun-24 4.65 4.85 4.97 4.65
Jun-25 4.93 4.85 4.95 4.72
Jun-26 4.98 5.03 5.17 4.82
Jun-27 5.01 4.90 5.11 4.85

Candel Therapeutics Earnings

Data Unavailable

Candel Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.61 per share, and a decrease next year of $0.09 per share.

* Candel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.